<p>Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling</p>-Reference-Cited by-同舟云学术

Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling

Published:2020-10 Issue: Volume:Volume 13 Page:11031-11044
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Cai Xiaomin,Wei Bin,Li Lele,Chen Xiaofeng^ORCID,Yang Jing,Li Xiaofei,Jiang Xiaozheng,Lv Mu,Li Mingyang,Lin Yumeng,Xu Qiang,Guo Wenjie^ORCID,Gu Yanhong

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference48 articles.

1. Colorectal cancer statistics, 2020

2. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

3. Systemic Therapy for Metastatic Colorectal Cancer: Current Options, Current Evidence

4. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

5. FDA Approval Summary: TAS-102

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of neoadjuvant apatinib in combination with capecitabine and oxaliplatin for the therapy of locally advanced colorectal cancer: A retrospective study;Oncology Letters;2024-03-11

2. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer;Frontiers in Pharmacology;2023-09-01

3. Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets;Biomedicines;2023-08-23

4. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review);International Journal of Oncology;2022-12-27

5. Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer;Cancer Treatment Reviews;2022-11